Valiant Laboratories Limited - Investor Relations & Filings
Valiant Laboratories Limited specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and bulk drugs, with a primary focus on the production of Paracetamol. The company operates dedicated manufacturing facilities designed for the large-scale synthesis of analgesic and antipyretic compounds. By maintaining rigorous quality control standards and process efficiencies, it serves as a key supplier for formulations across various therapeutic segments. Its core business activities encompass the chemical processing and distribution of high-grade medicinal ingredients, catering to a diverse range of healthcare manufacturers. The organization prioritizes technical excellence in API synthesis and the optimization of production workflows to ensure a consistent supply of essential pharmaceutical components.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Trading Window | 2026-03-26 | English | |
| Copy of Newspaper Publication | 2026-02-13 | English | |
| Monitoring Agency Report | 2026-02-11 | English | |
| Outcome of Board Meeting | 2026-02-11 | English | |
| Outcome of Board Meeting | 2026-02-11 | English | |
| Board Meeting — Board Meeting Intimation | 2026-02-06 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 42171822 | Trading Window | 2026-03-26 | English | ||
| 42246532 | Copy of Newspaper Publication | 2026-02-13 | English | ||
| 42210096 | Monitoring Agency Report | 2026-02-11 | English | ||
| 42211157 | Outcome of Board Meeting | 2026-02-11 | English | ||
| 42211521 | Outcome of Board Meeting | 2026-02-11 | English | ||
| 43899017 | Board Meeting — Board Meeting Intimation | 2026-02-06 | English | ||
| 43899040 | Board Meeting — Financial Results | 2026-02-06 | English | ||
| 42225572 | Reply to Clarification- Financial results | 2026-01-23 | English | ||
| 42202547 | Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 2026-01-15 | English | ||
| 42219556 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-01-07 | English | ||
|
2025
5 filings
| |||||
| 42247653 | Action(s) taken or orders passed | 2025-12-26 | English | ||
| 42250937 | Trading Window | 2025-12-26 | English | ||
| 42265521 | Copy of Newspaper Publication | 2025-11-13 | English | ||
| 42317159 | Updates | 2025-11-11 | English | ||
| 42321281 | Monitoring Agency Report | 2025-11-11 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
| 4D Pharma PLC | DDDD | GB | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
Valiant Laboratories Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/59639/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=59639 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing - metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=59639 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=59639 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 59639}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Valiant Laboratories Limited (id: 59639)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.